Kassler-Taub Kenneth B. 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Kassler-Taub Kenneth B.
SVP, Regulatory & QA
Transactions
- Exercise/Conversion
Common Stock
2022-02-28+11,297→ 73,767 total - Exercise/Conversion
Common Stock
2022-02-28+18,244→ 92,011 total - Exercise/Conversion
Common Stock
2022-02-28+7,087→ 99,098 total - Tax Payment
Common Stock
2022-02-28$2.85/sh−13,241$37,737→ 85,857 total - Exercise/Conversion
Restricted Stock Units
2022-02-28−11,297→ 0 total→ Common Stock (11,297 underlying) - Exercise/Conversion
Restricted Stock Units
2022-02-28−18,244→ 18,243 total→ Common Stock (18,244 underlying) - Exercise/Conversion
Restricted Stock Units
2022-02-28−7,087→ 14,173 total→ Common Stock (7,087 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
- [F4]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.